Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | LV-NY-ESO TCR/sr39TK PBSC |
| Trade Name | |
| Synonyms | LV-NYESO TCR/sr39TK PBSC |
| Drug Descriptions |
LV-NYESO TCR/sr39TK PBSC are peripheral blood stem cells that have been engineered to express a NY-ESO-1-specific T-cell receptor and the sr39TK cell suicide gene, which may enhance anti-tumor immune response (PMID: 30409823) |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C146940 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Aldesleukin + LV-NY-ESO TCR/sr39TK PBSC + RV-NY-ESO TCR PBMC | Aldesleukin LV-NY-ESO TCR/sr39TK PBSC RV-NY-ESO TCR PBMC | 0 | 2 |
| LV-NY-ESO TCR/sr39TK PBSC | LV-NY-ESO TCR/sr39TK PBSC | 0 | 0 |